EBOS Group Limited (ASX:EBO)

Market Cap	4.51B -29.9%
Revenue (ttm)	12.27B -7.0%
Net Income	215.14M -20.8%
EPS	1.09 -22.9%
Shares Out	n/a
PE Ratio	20.97
Forward PE	17.07
Dividend	1.11 (5.20%)
Ex-Dividend Date	Sep 4, 2025

Volume	75,659
Average Volume	130,642
Open	21.79
Previous Close	22.15
Day's Range	21.35 - 22.08
52-Week Range	21.35 - 38.23
Beta	0.25
RSI	33.26
Earnings Date	Feb 25, 2026

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1922
• Employees: 5,770
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EBO

Financial Performance

In fiscal year 2025, EBOS Group's revenue was 12.27 billion, a decrease of -6.99% compared to the previous year's 13.19 billion. Earnings were 215.14 million, a decrease of -20.77%.